Phase Ia/Ib trial of Anti-GD2 chimeric monoclonal antibody 14.18 (ch l4.18) and recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in metastatic melanoma
James L. Murray, Eugenie S. Kleinerman, Shu Fang Jia, Michael G. Rosenblum, Omar Eton, Antonio Buzaid, Sewa Legha, Merrick I. Ross, Lora Thompson, Kalpana Mujoo, Paula T. Rieger, Mansoor Saleh, M. B. Khazaeli, Saroj Vadhan-Raj
Research output: Contribution to journal › Article › peer-review
35Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Phase Ia/Ib trial of Anti-GD2 chimeric monoclonal antibody 14.18 (ch l4.18) and recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in metastatic melanoma'. Together they form a unique fingerprint.